The purchase is expected to allow the company to focus on manufacturing anthelmintics, such as Albendazol EP, Albendazole IP/USP, Cyromazine, Fenbendazole, BP VET / EP, Nitroxynil BP Vet,
Under the agreement, Nuron is responsible for development and commercialization of the vaccine. Financial terms of the agreement have not been disclosed. The DNA vaccine, which contains a
The proposed transaction could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation. PharmaLife is also expected to make safe, timely product registration within
As per the agreement, AnaptysBio will use its SHM-XEL platform to produce therapeutic antibodies to oncology and inflammation-related targets. Celgene will gain worldwide rights to develop and commercialize
VitaMedMD One Rx is a single daily dose softgel containing 14 vitamins, minerals, and 200mg of plant-based docosahexaenoic acid. The prenatal vitamin supplement contains the same combination of
The Phase I study will illustrate the safety profile of the combination and identify the appropriate dosing regimen to be used in the Phase II portion. Translational studies
The patents are set to expire 2024-2026, the company said. The Mexican patent covers the uses of Tß4 to treat or prevent biological or immunological responses to reactive
Production at Boehringer Ingelheim’s Ben Venue Laboratories factory in Ohio, US, was stopped in November 2011 due to product quality issues. Ben Venue said it may resume operations
AmiKet is indicated for the treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathy in patients previously treated with taxane-based chemotherapy. According to the FDA, products with a
The company has also received another $5m milestone payment, which was triggered by the European Medicines Agency (EMA) acceptance of the marketing authorization application. Peginesatide is currently under
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.